Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-07

Clinical Trial Update: A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perifosine in chemo-insensitive sarcomas, including chondrosarcoma, alveolar soft-part sarcoma, and extraskeletal myxoid chondrosarcoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Chondrosarcomas, Alveolar Soft Part Sarcomas | Phase 2 | Status: COMPLETED